Last Updated on December 31, 2023 by The Health Master
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for arformoterol tartrate inhalation solution, 15 mcg (base)/2 mL Unit-dose Vial.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brovana inhalation solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc.
Arformoterol tartarate inhalation solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.
Arformoterol tartrate inhalation solution, 15 mcg (base)/2 mL Unit-dose vial, has an estimated market size of US$ 251 million for twelve months ending December 2021 according to IQVIA.
Alembic has a cumulative total of 167 ANDA approvals (143 final approvals and 24 tentative approvals) from US FDA, including this second inhalational ANDA approval.
Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.
USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam
USFDA gives tentative approval for this Hypertension drug
USFDA gives tentative nod to Zydus for Selexipag tablets
USFDA gives approval to Lupin Pregabalin capsules
USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream
USFDA gives nod to these companies for Bortezomib for injection
USFDA gives 10 observations to Sun Pharm
CDSCO extends timeline for importing of drugs with shelf life less than 60%
FAQs – on Blood Bags and its Testing
USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam
IPC releases IP 2022, 92 new monograph, 27 APIs added: Read details
USFDA gives tentative approval for this Hypertension drug
Man held in Internet pharmacy racket, Rs 3.17 cr cash seized
Man gets 10-years rigorous imprisonment for making drugs illegally
USFDA gives tentative nod to Zydus for Selexipag tablets
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
